Kuanping Capital
Overview
Kuanping Capital is a healthcare-dedicated private equity firm that focuses on research-based, strategy-oriented active investments in the medical and healthcare sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nuanwa Technology | Aug 2019 | Angel | Co-investor |
| Shanghai Golden Leaf Med Tech Co., Ltd. | Apr 2021 | Series B Extension | Lead |
| Gege Medical Technology (Shanghai) Co., Ltd. | Feb 2021 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Kuanping Capital based?
Kuanping Capital is headquartered in Shanghai, China.
When was Kuanping Capital founded?
Kuanping Capital was founded in 2016.
How many portfolio companies does Kuanping Capital have?
Kuanping Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Kuanping Capital's portfolio?
Portfolio companies visible on Caplight include Nuanwa Technology, Shanghai Golden Leaf Med Tech Co., Ltd., Gege Medical Technology (Shanghai) Co., Ltd..
What was Kuanping Capital's most recent investment shown here?
Kuanping Capital's most recent investment in this portfolio sample was in Shanghai Golden Leaf Med Tech Co., Ltd. in 2021.
What sectors does Kuanping Capital focus on?
Kuanping Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Enterprise Software, Consumer & Commerce.
What company stages does Kuanping Capital focus on?
Kuanping Capital typically invests at the Mid stage.